TrialDiabetes care2021

Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT.

Muhammad Abdul-Ghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.